Systemic lupus erythematosus with hepatic artery aneurysm and large vessel vasculitis

Click to increase image sizeClick to decrease image size

Disclosure statement

TK has received speaking fees and/or honoraria from Tanabe Mitsubishi, Kissei, Pfizer, Amgen, Chugai, Daiichi-Sankyo, Eli Lilly, Eisai, Novartis, and Janssen, and received grants and speaking fees from GlaxoSmithKline. HS has received fees from Pfizer, Bristol-Myers Squibb, Eli Lilly, Sanofi, AbbVie, GlaxoSmithKline, Gilead, Boehringer Ingelheim, Jansen, Novartis, Chugai, Astellas, Eisai, Asahi Kasei, Taisho Pharmaceutical, AstraZeneca, and Daiichi-Sankyo. KF has received speaking fees and/or honoraria from Tanabe Mitsubishi, Bristol-Myers Squibb, Eli Lilly, Chugai, Jansen, Pfizer, Ono, AbbVie, Ayumi, Astellas, Sanofi, Novartis, Daiichi Sankyo, Eisai, Asahi Kasei, and AstraZeneca, and has received research grants from Tanabe Mitsubishi, Bristol-Myers Squibb, Eli Lilly, Chugai, Eisai, Tsumura, and Asahi Kasei. The other authors declare no conflicts of interest associated with this manuscript.

Consent

Written informed consent was obtained from the patient.

Data availability statement

The data related to this article will be shared upon reasonable request to the corresponding author.

Additional information

Funding

The authors reported that there is no funding associated with the work featured in this article.